No­var­tis CAR-T chief drops out of Big Phar­ma, joins the great mi­gra­tion to a fa­vorite biotech des­ti­na­tion

No­var­tis may still have big plans for CAR-T, but the phar­ma gi­ant con­tin­ues to bleed top tal­ent from the group.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.